2022's Top 5 Countries Struggling with the Highest Lung Cancer Rates

Endobronchial Ultrasound Market

The endobronchial ultrasound market is expanding due to two major factors, including the rising prevalence of lung cancer across the globe and the increasing rate of geriatric population susceptible to several diseases like respiratory diseases. Endobronchial ultrasound and endobronchial ultrasound-guided transbronchial needle aspiration are mainly used to assess pulmonary nodules, diagnose lung infections, and ascertain stages of lung cancer. Lung cancer is the most common reason of death across the globe.

• According to the data published by the American Cancer Society, the US reported nearly 238,340 new cases of lung cancer in 2023. 117,550 cases in men and 120,790 in women. Also, 127,070 deaths were registered due to lung cancer. 

Increase in preference for minimally invasive surgeries, further driving the endobronchial ultrasound biopsy. Another driving reason for this market is the increasing geriatric population across the globe, as chronic diseases increase with age. Many studies show that EBUS-TBNA is a safe and efficient method for people aged more than 65 years. 
Additionally, less invasive methods provide easy and faster healing, lesser incision, and minimum discomfort, thus are gaining traction for many individuals looking for solutions to tackle health issues.